Oncology News

Oncology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Woodall CE et al. - Morphological characteristics consistent with decreased esophagitis and incidences of metaplasia and esophageal adenocarcinoma were seen on histopathology in the resveratrol group. Resveratrol resulted in a small diminution of the carcinogenic effects and progression to metaplasia, and further human studies are designed to explore the potential anticarcinogenic mechanism.

Related Articles

MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival
Clinical Cancer Research, 10/01/09    Relevance Score: 67%

Increased risk of oesophageal adenocarcinoma among upstream petroleum workers
Occupational and Environmental Medicine, 11/06/09    Relevance Score: 66%

Preoperative and Early Postoperative Quality of Life Predict Survival in Potentially Curable Patients with Esophageal Cancer
Annals of Surgical Oncology, 10/20/09    Relevance Score: 66%

Sweets syndrome with neurologic manifestations in a patient with esophageal adenocarcinoma: case report and review of the literature
International Journal of Dermatology, 10/01/09    Relevance Score: 65%

Role of a novel bile acid receptor TGR5 in the development of esophageal adenocarcinoma
Gut, 11/23/09    Relevance Score: 64%

Today in Carcinogenesis...keeping you current

Regulating the leukaemia stem cell
Best Practice & Research: Clinical Haematology , 12/09/09

Aggressive inherited and sporadic medullary thyroid carcinomas display similar oncogenic pathways
Endocrine-Related Cancer, 12/08/09

Activation of the hedgehog-signaling pathway in human cancer and the clinical implications
Oncogene, 11/30/09

Today in GI Oncology...keeping you current

Extracapsular lymph node spread
Cancer, 12/10/09

Variations in gastric cancer care
Cancer, 12/10/09

Adherence to a Mediterranean diet and risk of gastric adenocarcinoma within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study
American Journal of Clinical Nutrition, 12/10/09